Clinical Trial Update: Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating carboplatin and pemetrexed with or without OGX-427 in untreated stage IV non-squamous non-small cell lung cancer has completed; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CARBOPLATIN (Carboplatin)
• OGX-427 (apatorsen)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Non Squamous Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-06-08